New targeted therapy to treat facial lesions

Research conducted by Roy G. Geronemus, M.D. and Yoon-Soo Cindy Bae-Harboe, M.D., was selected as Editor's Choice for the November 2013 issue of Lasers in Surgery and Medicine (LSM).

The manuscript titled "Targeted Topical and Combination Laser Surgery for the Treatment of Angiofibromas" was published in LSM, the official journal of the American Society for Laser Medicine and Surgery, Inc. (ASLMS).

Using a variety of laser technologies and a new topical medicine, the authors described an innovative way to treat angiofibromas, characteristically seen in patients with Tuberous Sclerosis. Angiofibromas are persistent facial lesions that are difficult to treat as they recur. The application of a new , topical sirolimus, works synergistically with and prolongs the effects of treatment.

"We described our method of combining these treatments to manage the angiofibromas of Tuberous Sclerosis. We hope to continue to pioneer innovative approaches to treating difficult skin problems by incorporating novel medical therapies with laser technology," said Dr. Geronemus.

Dr. Geronemus directs the Laser & Skin Surgery Center of New York, where they are investigating a diverse array of skin concerns including, but not limited to: scars, stretch marks, volume loss, alternatives to neuromodulators for rhytides, fat reduction, tattoo removal, port wine stains, dyspigmentation, alopecia, hair removal, and more. He is Clinical Professor of Dermatology at the New York University Medical Center.

The Editor-in-Chief of LSM, J. Stuart Nelson, M.D., Ph.D. commented on the study, "The angiofibromas of Tuberous Sclerosis (TS) is a frustrating, persistent, recurrent skin problem with very limited treatment options. In the manuscript, the authors explore the potential benefits of merging novel topical agents with laser surgery to increase penetration of targeted therapy into the site of pathology. This report compels investigators to study this procedure in larger randomized clinical trials so that patients suffering from the stigma of these lesions can be effectively treated."

More information: www.aslms.org/professional/doc… sChoiceLSMNov459.pdf

Related Stories

Novel approach found for treating hypertrophic scars

date Mar 27, 2013

(HealthDay)—Same-session therapy with fractional ablative laser treatment followed immediately with topical application of triamcinolone acetonide suspension is effective in treating patients with hypertrophic ...

Ablative carbon dioxide laser effective for rhinophyma

date Oct 17, 2013

(HealthDay)—Good cosmetic outcomes are possible using fractionated ablative carbon dioxide laser therapy for mild-to-moderate cases of rhinophyma, according to research published online Oct. 5 in Lasers in ...

Recommended for you

Level I trauma experience prepares surgeons for battle

date 9 hours ago

Soldiers injured during the conflicts in Iraq and Afghanistan have the highest survival rates in history, thanks to the availability of surgeons skilled in combat care. But combat-ready surgical skills are hard to sustain ...

Surgery may help adolescents with frequent migraines

date Jun 29, 2015

(HealthDay)—Migraine surgery may be an effective choice for adolescents who haven't gotten relief from standard treatment, a small study suggests. The findings were published in the June issue of Plastic an ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.